Supramolecular PEGylation of biopharmaceuticals

Supramolecular PEGylation of biopharmaceuticals

The covalent modification of therapeutic biomolecules has been broadly explored, leading to a number of clinically approved modified protein drugs. These modifications are typically intended to address challenges arising in biopharmaceutical practice by promoting improved stability and shelf life of...

Full description

Bibliographic Details
Main Authors: Vinciguerra, Brittany, Thapa, Lavanya S., Jhunjhunwala, Siddharth, Isaacs, Lyle, Webber, Matthew, Appel, Eric, Cortinas, Abel Bryan, Langer, Robert S, Anderson, Daniel Griffith
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Format: Article
Language:en_US
Published: National Academy of Sciences (U.S.) 2017
Online Access:http://hdl.handle.net/1721.1/111202
https://orcid.org/0000-0003-0624-3532
https://orcid.org/0000-0002-2301-7126
https://orcid.org/0000-0002-8227-953X
https://orcid.org/0000-0003-4255-0492
https://orcid.org/0000-0001-5629-4798

Internet

http://hdl.handle.net/1721.1/111202
https://orcid.org/0000-0003-0624-3532
https://orcid.org/0000-0002-2301-7126
https://orcid.org/0000-0002-8227-953X
https://orcid.org/0000-0003-4255-0492
https://orcid.org/0000-0001-5629-4798

Similar Items